Global Nanomedicine Market to Reach $130.9 Billion by 2016

Global Information has added a business report titled ‘Nanotechnology in Medical Applications: The Global Market’ to its offering.

According to the report published by BCC Research, the market value of the worldwide nanomedicine industry was $63.8 billion and $72.8 billion in 2010 and 2011, respectively. The market is estimated to grow at a CAGR of 12.5% to reach $130.9 billion by the fiscal year 2016.

The market for central nervous system products was valued at $11.7 billion in the fiscal year 2010 and $14 billion in the fiscal year 2011. It is anticipated to grow at 16.1% CAGR to reach $29.5 billion by the fiscal year 2016. The market for anti-cancer products was valued at $28 billion in the fiscal year 2011 when compared to the 2010 value of $25.2 billion. It is anticipated to reach $46.7 billion by the fiscal year 2016 for a CAGR of 10.8% during the period 2011-2016.

The well-established nanomedicine market has developed numerous products whose efficacy is attributable to their nano dimension. The report discusses major technologies used in nanomedicine. Cardiovascular, infections, CNS diseases and cancer are the therapeutic categories covered in the report. The United States, the United Kingdom, France, Italy, Germany, Japan, and Spain are the geographic markets included in the report.

The strategic report analyzes the pharmaceutical market’s current size and growth in detail. It has profiled more than 60 major companies, with up-to-date merger and acquisition data. It provides sales forecasts for the country markets and the products in the main therapeutic categories.

Source: http://www.giiresearch.com